An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...
The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...
"It's frankly scary what people will put up with when they're losing weight" Dr Michael Crotty on the rollout of Mounjaro ...
AUGUSTA, Ga. (WRDW/WAGT) - A new report from Augusta University shows Georgia is the second lowest state for adults with ...
4h
Verywell Health on MSNDoes Berberine Really Aid Weight Loss? A Registered Dietitian ExplainsThe body does not absorb berberine well, limiting its ability to affect body weight significantly. However, berberine may enhance a weight-loss routine, given its safety and tolerability. Still, ...
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
CINCINNATI (WKRC) - Sunday is the second biggest eating day of the year, trailing only Thanksgiving. However, there are ways to cut calories and improve your menu by incorporating foods that are ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
A medical professional has issued a stark warning about four everyday habits that could be wreaking havoc on your heart ...
15h
GlobalData on MSNPalatin concludes Phase II trial of combination therapy for obesityPalatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin 4 ...
Truist lowered the firm’s price target on Viking Therapeutics (VKTX) to $95 from $120 and keeps a Buy rating on the shares. The company’s Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results